Tel Aviv University 
Welcome,         Profile    Billing    Logout  
 1 Product   0 Diseases   1 Product   1 Trial   8471 News 


«12345678910111213...6869»
  • ||||||||||  NurOwn (MSC-NTF) / BrainStorm Cell Therap
    what about #NurOwn ? (Twitter) -  Mar 19, 2022   
  • ||||||||||  NurOwn (MSC-NTF) / BrainStorm Cell Therap
    CSF biomarkers evaluated by principal component analysis in a NurOwn Phase 3 clinical trial ([VIRTUAL]) -  Mar 6, 2022 - Abstract #AAN2022AAN_1759;    
    P3
    ALS is a complex disease in which neurodegeneration, neuroinflammation and failure of intrinsic neuroprotective mechanisms may play an important role1. NurOwn treatment resulted in consistent longitudinal changes in specific CSF neurodegenerative, neuroinflammatory, and neuroprotection biomarkers and within biomarker categories as identified by PCA analysis.PCA analysis of NurOwn treatment effects across biomarker categories contributes to the understanding of its mechanism of action in ALS.
  • ||||||||||  NurOwn (MSC-NTF) / BrainStorm Cell Therap
    Nurown isnt it (Twitter) -  Mar 4, 2022